null
null
OncologyStat
®
One Source, Many Resources.
®
By Elsevier
NON-HODGKIN'S LYMPHOMA
Refine Results:
All Categories
Epidemiology and Etiology (195)
Prevention and Screening (53)
Diagnosis and Staging (270)
Treatment (547)
Supportive Oncology (52)
CME
Treatment Advances in Lymphoma: What's New from ASH 2011
An interactive CME program Powered by RealCME
Clinical Cliffhangers: Case-Based Challenges for the Risk Assessment and Prophylaxis of Tumor Lysis Syndrome
An interactive CME program provided by Med-IQ
Advances in the Management of B-Cell and T-Cell Lymphomas—Highlights from the 53rd American Society of Hematology Annual Meeting and Exposition
An interactive CME program provided by Educational Concepts Group, LLC
News
EMA Okays Pixantrone Conditionally for Non-Hodgkin’s Lymphoma
Elsevier Global Medical News, 2012 Feb 21, J Smith
FDA: Rare Brain Infection Prompts Boxed Warning for Brentuximab
Elsevier Global Medical News, 2012 Jan 13, D Mahoney
'Best Results' Yet for Poor-Prognosis Elderly With DLBCL
Elsevier Global Medical News, 2012 Jan 4, N Osterweil
Cell Therapeutics' Dual Strategy on Pixuvri Will Be Tested at Advisory Committee
The Pink Sheet Daily, 2011 Dec 29, M Berman-Gorvine
Mantle Cell Lymphoma: BTK Inhibitor Scores Again
Elsevier Global Medical News, 2011 Dec 15, N Osterweil
More News ›
Journal Scans: Research
Cancer Incidence in Patients With Polyglutamine Diseases
Lancet Oncol, 2012 Apr 12, J Ji, et al
The Impact of Platelet Transfusion Characteristics on Post-Transfusion Platelet Increments and Clinical Bleeding in Patients With Hypo-Proliferative Thrombocytopenia
Blood, 2012 Apr 10, DJ Triulzi, et al
The Absolute Monocyte Count Is Associated With Overall Survival in Patients Newly Diagnosed With Follicular Lymphoma
Leukemia and Lymphoma, 2012 Apr 1, RA Wilcox, et al
Incidence, Risk Factors and Outcome of Histological Transformation in Follicular Lymphoma
Br J Haematol, 2012 Apr 1, A Conconi, et al
Radiotherapy Alone With Curative Intent in Patients With Stage I Extranodal Nasal-Type NK/T-Cell Lymphoma
Int J Radiat Oncol Biol Phys, 2012 Apr 1, YX Li, et al
More Journal Scans: Research ›
Journal Scans: Review
Primary Lymphoma of the Ocular Adnexa (Orbital Lymphoma) and Primary Intraocular Lymphoma
Clin Oncol, 2012 Apr 23, DK Woolf, et al
Primary Brain Tumours in Adults
Lancet, 2012 Apr 16, D Ricard, et al
Recent Advances in the Management of Cutaneous Lymphomas
Semin Oncol, 2012 Apr 1, B Belloni, et al
Role of Histone Deacetylase Inhibitors in the Treatment of Lymphomas and Multiple Myeloma
Hematol Oncol Clin North Am, 2012 Mar 27, J Zain
Why Does My Patient Have Lymphadenopathy or Splenomegaly?
Hematol Oncol Clin North Am, 2012 Mar 14, G Motyckova, et al
More Journal Scans: Review ›
Expert Opinion
Seminal Articles—Lymphoma
2012 Mar 26, Andre Goy, et al
Seminal Articles—Growth Factor Support
2012 Mar 26, David Henry, et al
PCI-32765 Is One of the Most Exciting Drugs Around
2012 Mar 19, Susan O’Brien, et al
Dr. Andre Goy: The B-cell Inhibitors Will be Game-Changing in B-cell Lymphoma and CLL
2012 Feb 8, Andre Goy, et al
Ask the Expert: Zoledronic Acid in Late-Stage DLBCL With Bone Involvement
2012 Jan 30, Andre Goy, et al
More Expert Opinion ›
Chemotherapy Regimens
Rituximab/hyper CVAD (cyclophosphamide, vincristine, doxorubicin [Adriamycin], dexamethasone) alternating with methotrexate, – cytarabine (Non-Hodgkin's lymphoma)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Rituximab/EPOCH (etoposide, prednisone, – vincristine [Oncovin], doxorubicin, cyclophosphamide) (Non-Hodgkin's lymphoma)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Rituximab/CHOP (cyclophosphamide, doxorubicin, vincristine [Oncovin], prednisone) (Non-Hodgkin's lymphoma)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Rituximab (Non-Hodgkin's lymphoma)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Hyper CVAD (cyclophosphamide, vincristine, doxorubicin [Adriamycin], dexamethasone) alternating with methotrexate, cytarabine (Non-Hodgkin's lymphoma)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
More Chemotherapy Regimens ›
Conference Coverage
2011 ASH Annual Meeting and Exposition
Dec 10-13 2011 San Diego, et al
16th Congress of EHA
June 9-12 2011 London
Videos
Bendamustine Plus Rituximab as First-Line Lymphoma Treatment
Elsevier Global Medical News, 2009 Dec 16, P Wendling
Fostamatinib for Leukemia, Lymphoma
Elsevier Global Medical News, 2008 Dec 6, JS MacNeil
National Clinical Trial Underway in Follicular Lymphoma
ASCO, 2007 Jun 4, Edwina Bakin-Bey MD
Summary of Key Points
Non-Hodgkin's Lymphoma
Abeloff's Clinical Oncology, 4th ed. 2008
Comment
Print page
Share page
RSS feeds
Updated Key Points: Non-Hodgkin's Lymphoma
Summary information about non-Hodgkin's lymphoma has been completely revised with updated information from Abeloff's Clinical Oncology, 4th ed.
Read more ›
Seminal Articles
The definitive list of must-read articles for practicing oncologists
Read more ›
Categories
News
Journal Scans
Expert Opinion
Drugs and Regimens
Conferences
CME
Videos
Supportive Care
Skeletal-Related Events
Complications, GI and Oral
Hematologic Support
Infectious Complications
Neurologic Complications
Pain
Vascular Complications
Cancer Type
Bladder
Bone
Breast
Breast (ER-Positive)
CNS/Brain
Colon and Rectum
Endocrine System
Esophagus
GYN (Non-Ovary)
GYN (Ovary)
Head and Neck
Hodgkin's Lymphoma
Kidney (Renal Cell)
Leukemia
Liver and Bile Duct
Lung
Multiple Myeloma
Myelodysplastic Syndrome
Myeloproliferative Diseases
Non-Hodgkin's Lymphoma
Pancreas
Pediatric Cancers
Prostate
Rare Cancers
Skin
Soft-Tissue Sarcoma
Stomach
Testicle
NonHodgkinsLymphoma/
anonymous
none
none
none
n
Advanced Search
Email Address
Password
Remember Me
Forgot your password?
Not a member?
Free registration
Elsevier
Home
Site Map
Cancer Types
About OncologySTAT
Privacy Policy
Terms of Use
Contact Us
Advertise
Copyright © 2012
Elsevier Inc.
All rights reserved.